MAPT and tauopathy: For instance, expression of the aggregate-prone mutant tau species in the P301S tauopathy mouse model is driven by the murine Thy1 promoter, which leads to the development of pathology in selected CNS cell types and consequently specific regions (Allen et al., 2002).